Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKinsey
Johnson and Johnson
Mallinckrodt
Baxter
Express Scripts
Dow

Last Updated: January 20, 2020

DrugPatentWatch Database Preview

Patent: 7,867,529

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Summary for Patent: 7,867,529
Title:Method for reducing acrylamide in foods, foods having reduced levels of acrylamide and article of commerce
Abstract: A method for the reduction of acrylamide in food products, food products having reduced levels of acrylamide, and an article of commerce. In one aspect, the method comprises reducing the level of asparagine in a food material before final heating (e.g., cooking). In another aspect, the method comprises adding to a food material an enzyme capable of hydrolyzing the amide group of free asparagine. In yet another aspect, an article of commerce communicates to the consumer that a food product has reduced or low levels of acrylamide or asparagine.
Inventor(s): Zyzak; David Vincent (Mason, OH), Sanders; Robert Alan (Fairfield, OH), Stojanovic; Marko (Cincinnati, OH), Gruber; David Cammiade (Cincinnati, OH), Lin; Peter Yau Tak (Liberty Township, OH), Villagran; Maria Dolores Martinez-Serna (Mason, OH), Howie; John Keeney (Oregonia, OH), Schafermeyer; Richard Gerard (Cincinnati, OH)
Assignee: The Procter & Gamble Company (Cincinnati, OH)
Application Number:12/390,540
Patent Claims:see list of patent claims

Details for Patent 7,867,529

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Merck ELSPAR asparaginase VIAL 101063 001 1978-01-10   Start Trial The Procter & Gamble Company (Cincinnati, OH) 2022-09-20 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Harvard Business School
Mallinckrodt
Merck
Colorcon
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.